OMC
COEPW

Old Mission Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Old Mission Capital’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,558
Closed -$1.15K – 1480
2022
Q4 		$1.15K Buy
+11,558
New +$772 ﹤0.01% 1352
2022
Q3 		– Sell
-11,458
Closed – – 1011
2022
Q2 		$0 Buy
+11,458
New +$860 ﹤0.01% 1502

Other funds holding COEPW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Old Mission Capital's COEPW Position: Q1 2023 in Review

Old Mission Capital sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2023, closing a stake of 11,558 shares — an estimated $1.15K sold.

Old Mission Capital first reported a position in COEPW in Q2 2022 and held it in 2 quarters. The position peaked at $1.15K in Q4 2022. 18 funds tracked by Wall St. Rank hold COEPW as of Q1 2023.

  • Old Mission Capital reported no remaining Coeptis Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
  • Old Mission Capital sold 11,558 Coeptis Therapeutics Warrants shares in Q1 2023, an estimated $1.15K.
  • Old Mission Capital first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 2 quarters.
  • Old Mission Capital's Coeptis Therapeutics Warrants position peaked at $1.15K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.